Literature DB >> 29396654

Confounders for interpreting the benefit of a biomarker-based strategy in early discontinuation of empirical antifungal therapy.

Satoshi Yamaga1, Shinichiro Ohshimo2, Nobuaki Shime1, Saad Nseir3,4,5, Boualem Sendid3,4,6, Anahita Rouzé3,4,5.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29396654     DOI： 10.1007/s00134-018-5068-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

Authors:  O A Cornely; M Bassetti; T Calandra; J Garbino; B J Kullberg; O Lortholary; W Meersseman; M Akova; M C Arendrup; S Arikan-Akdagli; J Bille; E Castagnola; M Cuenca-Estrella; J P Donnelly; A H Groll; R Herbrecht; W W Hope; H E Jensen; C Lass-Flörl; G Petrikkos; M D Richardson; E Roilides; P E Verweij; C Viscoli; A J Ullmann
Journal:  Clin Microbiol Infect       Date:  2012-12       Impact factor: 8.067

2.  Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score-derived analysis of a population-based, multicentre prospective cohort.

Authors:  L E López-Cortés; B Almirante; M Cuenca-Estrella; J Garnacho-Montero; B Padilla; M Puig-Asensio; I Ruiz-Camps; J Rodríguez-Baño
Journal:  Clin Microbiol Infect       Date:  2016-05-14       Impact factor: 8.067

3.  Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial.

Authors:  Anahita Rouzé; Séverine Loridant; Julien Poissy; Benoit Dervaux; Boualem Sendid; Marjorie Cornu; Saad Nseir
Journal:  Intensive Care Med       Date:  2017-09-22       Impact factor: 17.440

4.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

5.  Factors predicting prolonged empirical antifungal treatment in critically ill patients.

Authors:  Mohamed Zein; Erika Parmentier-Decrucq; Amer Kalaoun; Olivier Bouton; Frédéric Wallyn; Anne Baranzelli; Dia Elmanser; Boualem Sendid; Saad Nseir
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-03-11       Impact factor: 3.944
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.